```html

Xanthomas (Tendinous): A Complete Patient‑Friendly Guide

Overview

What are tendinous xanthomas? Tendinous xanthomas are firm, yellow‑to‑orange nodules that appear within tendons, most commonly the Achilles tendon, extensor tendons of the hands, and the quadriceps tendon. They are composed of lipid‑laden macrophages (foam cells) that accumulate in the connective tissue of the tendon.

Who is affected? They primarily occur in people with markedly elevated low‑density lipoprotein (LDL) cholesterol, especially those with familial hypercholesterolemia (FH). Both men and women can develop them, but men tend to present earlier (late teens to early 30s) because FH is X‑linked recessive in ~2‑5 % of cases and autosomal dominant in the majority.

Prevalence – Tendinous xanthomas are relatively rare in the general population (<0.1 %). However, among individuals with heterozygous FH, the prevalence rises to 10‑20 % and reaches >80 % in untreated homozygous FH patients.<sup>[1] Mayo Clinic</sup> Worldwide, FH affects approximately 1 in 250 people, making tendinous xanthomas an important clinical clue for early detection of severe dyslipidemia.

Symptoms

Tendinous xanthomas are usually painless, but they can cause functional limitations depending on size and location. Common symptoms include:

• Visible nodules – Yellow‑orange, firm bumps felt under the skin, most often over the Achilles tendon or on the dorsal hands.
• Localized tenderness – May become tender after prolonged activity or pressure.
• Reduced range of motion – Large lesions can restrict tendon flexibility, making walking, climbing stairs, or gripping objects uncomfortable.
• Swelling – Occasionally, surrounding tissue becomes mildly edematous.
• Skin changes – The overlying skin may appear thin or slightly erythematous if the lesion is irritated.
• Associated systemic signs – Because they signal high LDL, patients often have a family history of premature cardiac disease, corneal arcus, or other cutaneous xanthomas (e.g., tuberous or eruptive).

Most people first notice the nodules incidentally while shampooing, showering, or during routine physical exam.

Causes and Risk Factors

Tendinous xanthomas are not a disease in themselves; they are a manifestation of underlying lipid metabolism disorders.

Primary causes

• Familial Hypercholesterolemia (FH) – Autosomal dominant mutations in the LDLR, APOB, or PCSK9 genes lead to lifelong LDL‑cholesterol >190 mg/dL.
• Familial Defective Apolipoprotein B‑100 – Similar LDL elevation due to impaired receptor binding.
• Other rare lipid disorders – Such as sitosterolemia or cholesteryl ester storage disease.

Risk factors that increase the likelihood of developing tendinous xanthomas

• Untreated or poorly controlled FH (heterozygous or homozygous)
• Family history of early‑onset coronary artery disease (CAD) or known xanthomas
• Male sex (higher penetrance in men)
• Age > 15 years in FH carriers (lesions often appear after puberty)
• Smoking – accelerates atherosclerosis and may worsen lipid profiles
• Obesity and metabolic syndrome – can coexist with dyslipidemia, though they are not direct causes of tendinous xanthomas.

Diagnosis

Diagnosis is clinical, supported by imaging and laboratory studies to confirm the underlying lipid disorder.

Clinical evaluation

• Physical examination – inspection and palpation of tendons, especially Achilles and extensor tendons of the hands.
• Family history – documenting cholesterol levels, premature CAD, or known xanthomas.

Laboratory tests

• Lipid panel – LDL‑C, total cholesterol, HDL‑C, triglycerides. In FH, LDL‑C is frequently >190 mg/dL (heterozygous) or >400 mg/dL (homozygous).<sup>[2] CDC</sup>
• Genetic testing – Targeted panels for LDLR, APOB, PCSK9 mutations; recommended when FH is suspected.

Imaging studies

• Ultrasound – First‑line; shows hyperechoic thickening of the tendon with well‑defined nodules.
• MRI – Provides detailed soft‑tissue contrast; useful when lesions are large or cause functional impairment.
• CT scan – Rarely needed but can illustrate calcified components.

Biopsy (rare)

Skin or tendon biopsy is reserved for atypical cases; histology reveals lipid‑laden macrophages (foam cells) within the tendon matrix.

Treatment Options

Management focuses on two goals: eliminate the underlying lipid abnormality and address the tendon lesions if they cause symptoms.

Medication

• Statins (e.g., atorvastatin, rosuvastatin) – First‑line agents; reduce LDL‑C by 30‑50 %.<sup>[3] NIH</sup>
• Ezetimibe – Inhibits intestinal cholesterol absorption; adds ~15‑20 % LDL reduction when combined with a statin.
• PCSK9 inhibitors (evolocumab, alirocumab) – Monoclonal antibodies that lower LDL‑C up to 60 % and are especially effective in FH resistant to statins.
• Bile‑acid sequestrants (cholestyramine) – Useful adjuncts when maximal LDL lowering is needed.
• Lipid‑apo‑A1 infusion (experimental) – Investigational therapy under clinical trials.

Procedural options for the tendon lesions

• Surgical excision – Indicated for large, painful xanthomas that impair mobility. Requires careful tendon reconstruction.
• Laser‑assisted removal – Emerging technique for superficial lesions on the hand; limited data.
• Observation – Most tendinous xanthomas are asymptomatic; if LDL is well controlled, lesions often stabilize or shrink without surgery.

Lifestyle modifications

• Adopt a heart‑healthy diet (Mediterranean or DASH); limit saturated fat, trans‑fat, and dietary cholesterol.
• Engage in regular aerobic activity (≥150 min/week) to improve lipid profile.
• Maintain a healthy weight (BMI 18.5‑24.9 kg/m²).
• Avoid tobacco and excessive alcohol.
• Regularly monitor cholesterol levels per physician recommendation (usually every 3–12 months).

Living with Xanthomas (Tendinous)

While the nodules themselves are not dangerous, they serve as a visible reminder of a serious cardiovascular risk. Below are practical tips for daily life.

Self‑examination

• Check the Achilles tendon and the backs of hands monthly for changes in size or tenderness.
• Take photos to track gradual growth.

Footwear & activity

• Choose cushioned, supportive shoes to reduce pressure on the Achilles tendon.
• If you experience pain during running or climbing stairs, switch to low‑impact activities (swimming, cycling) until the lesion stabilizes.

Skin care

• Keep the overlying skin clean and moisturized; avoid harsh scrubbing that could trigger irritation.
• Apply a hypoallergenic barrier cream if the lesions rub against clothing.

Medication adherence

• Set daily alarms or use a pill‑organizer.
• Discuss any side‑effects with your provider promptly – many statin‑related muscle symptoms are manageable.

Psychosocial aspects

• Cosmetic concerns are common; consider counseling or support groups for patients with FH.
• Inform close family members about your diagnosis; cascade screening can identify relatives who need treatment.

Prevention

Primary prevention is centered on early detection and aggressive lipid control.

• Screening – Universal lipid panel once between ages 9‑11 and again at 17‑21, per American Heart Association guidelines.<sup>[4] AHA</sup>
• Family cascade testing – If FH is diagnosed, test first‑degree relatives.
• Nutrition from childhood – Encourage fruits, vegetables, whole grains, and lean proteins.
• Physical activity – Instill active habits early; treadmill walking or family bike rides are effective.
• Avoid smoking – Even occasional tobacco use can worsen lipid abnormalities.

Complications

If the underlying hyperlipidemia is untreated, tendinous xanthomas are a marker for serious systemic disease.

• Atherosclerotic cardiovascular disease (ASCVD) – Premature coronary artery disease, myocardial infarction, stroke. FH patients have a 20‑30 % risk of a major cardiac event before age 50.<sup>[5] WHO</sup>
• Peripheral arterial disease – Reduced blood flow to limbs, leading to claudication.
• Growth of xanthomas – Large lesions can cause tendon rupture or chronic pain.
• Psychological impact – Cosmetic disfigurement may lead to anxiety or depression.

When to Seek Emergency Care

References

1. Mayo Clinic. “Familial hypercholesterolemia.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “High Cholesterol Facts.” 2022. https://www.cdc.gov
3. National Institutes of Health. “Statins: How They Work.” 2023. https://www.nhlbi.nih.gov
4. American Heart Association. “Lipid Screening Guidelines.” 2022. https://www.heart.org
5. World Health Organization. “Familial hypercholesterolemia.” 2023. https://www.who.int

```